Incidence and survival rates of primary cutaneous malignancies in Korea, 1999-2019: A nationwide population-based study
- PMID: 38366757
- DOI: 10.1111/1346-8138.17118
Incidence and survival rates of primary cutaneous malignancies in Korea, 1999-2019: A nationwide population-based study
Abstract
Primary cutaneous malignancies are among the most commonly diagnosed types of cancer worldwide. We aimed to examine the incidence and 5-year survival rates of all types of primary cutaneous malignancies in the Korean population. Data from the Korean Nationwide Cancer Registry from 1999 to 2019 were analyzed. The crude incidence rates, age-standardized incidence rates, and 5-year relative survival rates of each type of skin cancer were calculated. A total of 89 965 patients were diagnosed with primary cutaneous malignancies, which was a 7-fold increase from 1999 to 2019. The age-standardized incidence rates increased 3.4-fold in basal cell carcinoma (3.7/100 000 person-years), 2.0-fold in squamous cell carcinoma (1.6/100 000 person-years), 12.0-fold in Bowen disease (1.2/100 000 person-years), and 1.8-fold in malignant melanoma (0.7/10 000 person-years) in 2019. Average annual percentage changes in age-standardized incidence rates were statistically significant in basal cell carcinoma (15.8%), Bowen disease (5.8%), squamous cell carcinoma (5.1%), malignant melanoma (1.2%), melanoma in situ (1.1%), dermatofibrosarcoma protuberans (1.2%), mycosis fungoides (0.5%), primary cutaneous CD30+ T-cell proliferations (0.5%), adnexal and skin appendage carcinoma (0.4%), extramammary Paget's disease (0.2%), and Merkel cell carcinoma (0.2%). The 5-year relative survival rates were the highest in basal cell carcinoma (103.3%), followed by dermatofibrosarcoma protuberans (99.7%) and mycosis fungoides (96.6%), and lowest in angiosarcoma (24.7%). The 5-year relative survival rates steadily increased in extramammary Paget's disease (23.6%), cutaneous B-cell lymphoma (21.3%), mycosis fungoides (20.2%), extranodal NK/T-cell lymphoma, nasal type (18.1%), and malignant melanoma (16.1%) from 1996-2000 to 2015-2019. Most primary cutaneous malignancies have increased in incidence and survival rates in the Korean population, but to varying extents depending on the type of skin cancer.
Keywords: epidemiology; incidence; skin neoplasms; survival rate.
© 2024 Japanese Dermatological Association.
Similar articles
-
Epidemiology of skin cancer based on Japan's National Cancer Registry 2016-2017.Cancer Sci. 2023 Jul;114(7):2986-2992. doi: 10.1111/cas.15823. Epub 2023 Apr 24. Cancer Sci. 2023. PMID: 37095610 Free PMC article.
-
Trends in incidence and survival of patients with vulvar cancer in an Asian country: Analysis of the Korean Central Cancer Registry 1999-2018.Gynecol Oncol. 2022 Feb;164(2):386-392. doi: 10.1016/j.ygyno.2021.11.017. Epub 2021 Dec 7. Gynecol Oncol. 2022. PMID: 34893346
-
Bowen's disease, Paget's disease, and malignant melanoma in situ.South Med J. 1986 Apr;79(4):410-3. doi: 10.1097/00007611-198604000-00005. South Med J. 1986. PMID: 2422766
-
Skin cancer in blacks in the United States.Dermatol Clin. 1988 Jul;6(3):397-405. Dermatol Clin. 1988. PMID: 3048822 Review.
-
Cutaneous malignancies of the perineum.Clin Obstet Gynecol. 2015 Mar;58(1):158-71. doi: 10.1097/GRF.0000000000000079. Clin Obstet Gynecol. 2015. PMID: 25517758 Review.
Cited by
-
Ethnic-Specific and UV-Independent Mutational Signatures of Basal Cell Carcinoma in Koreans.Int J Mol Sci. 2025 Jul 19;26(14):6941. doi: 10.3390/ijms26146941. Int J Mol Sci. 2025. PMID: 40725190 Free PMC article.
References
REFERENCES
-
- Lomas A, Leonardi‐Bee J, Bath‐Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166:1069–1080.
-
- Eisemann N, Waldmann A, Geller AC, Weinstock MA, Volkmer B, Greinert R, et al. Non‐melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol. 2014;134:43–50.
-
- Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella S, Meheus F, et al. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol. 2022;158:495–503.
-
- Yang DD, Borsky K, Jani C, Crowley C, Rodrigues JN, Matin RN, et al. Trends in keratinocyte skin cancer incidence, mortality and burden of disease in 33 countries between 1990 and 2017. Br J Dermatol. 2023;188:237–246.
-
- Park K, Bae JM, Chung KY, Yun SJ, Seo SH, Ahn HH, et al. Incidence and prevalence of skin cancers in South Korea from 2008 to 2016: a nation‐wide population based study. Ann Dermatol. 2022;34:105–109.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical